|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn646756590 |
003 |
OCoLC |
005 |
20231117033226.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
920520s1986 ne a ob 101 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d UBY
|d OCLCQ
|d OPELS
|d IDEBK
|d OCLCQ
|d UAB
|d OCLCQ
|d OCLCF
|d OCLCQ
|d LEAUB
|d VLY
|d OCLCO
|d COM
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 505131853
|a 742290722
|a 815682238
|a 823115668
|a 1162528112
|a 1397386396
|
020 |
|
|
|a 0444807330
|q (electronic bk.)
|
020 |
|
|
|a 9780444807335
|q (electronic bk.)
|
020 |
|
|
|a 1281716227
|
020 |
|
|
|a 9781281716224
|
020 |
|
|
|a 9786611716226
|
020 |
|
|
|a 661171622X
|
020 |
|
|
|a 0080861911
|
020 |
|
|
|a 9780080861913
|
035 |
|
|
|a (OCoLC)646756590
|z (OCoLC)505131853
|z (OCoLC)742290722
|z (OCoLC)815682238
|z (OCoLC)823115668
|z (OCoLC)1162528112
|z (OCoLC)1397386396
|
050 |
|
4 |
|a QP376
|b .P7666 1986eb
|
072 |
|
7 |
|a MJN
|2 bicssc
|
082 |
0 |
4 |
|a 616.8
|2 23
|
245 |
0 |
0 |
|a Progress in brain research.
|n Volume 66,
|p Peptides and neurological disease /
|c edited by P.C. Emson, M. Rossor and M. Tohyama.
|
260 |
|
|
|a Amsterdam ;
|a New York :
|b Elsevier,
|c 1986.
|
300 |
|
|
|a 1 online resource (ix, 380 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Progress in brain research ;
|v 66
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Peptides and Neurological Disease; Copyright Page; Contents; List of Contributors; Preface; Frequently Occurring Abbreviations; Section I: Introduction; Chapter 1. Immunohistochemical techniques; Section II: Basal Ganglia; Chapter 2. Distribution of peptides in basal ganglia; Chapter 3. Physiology of peptides in basal ganglia; Chapter 4. Neuropeptides and the pathology of Huntington's disease; Chapter 5. Neuropeptides and Parkinson's disease; Section III: Cerebral Cortex; Chapter 6. Morphology and distribution of peptide-containing neurones in the cerebral cortex
|
505 |
8 |
|
|a Chapter 7. Cerebral changes in Alzheimer's diseaseChapter 8. Neuropeptides and dementia; Chapter 9. Neuropeptides and schizophrenia; Section IV: Spinal Cord and Peripheral Nervous System; Chapter 10. Neuropeptides in spinal cord; Chapter 11. Neurochemistry and neural circuitry in the dorsal horn; Chapter 12. Peptides in the peripheral nervous system; Chapter 13. Peptides in body fluids in pain; Section V: Therapeutic Perspectives; Chapter 14. The design of antagonists of regulatory peptides, and comments on their specificity
|
505 |
8 |
|
|a Chapter 15. Studies on peptide comodulator transmission. New perspective on the treatment of disorders of the central nervous systemChapter 16. Clinical relevance of neuropeptide research; Subject Index
|
520 |
|
|
|a PEPTIDES AND NEUROLOGICAL DISEASE.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Neuropeptides
|x Testing.
|
650 |
|
0 |
|a Central nervous system
|x Diseases.
|
650 |
|
2 |
|a Central Nervous System Diseases
|0 (DNLM)D002493
|
650 |
|
6 |
|a Syst�eme nerveux central
|x Maladies.
|0 (CaQQLa)201-0011353
|
650 |
|
7 |
|a Central nervous system
|x Diseases
|2 fast
|0 (OCoLC)fst00850732
|
655 |
|
2 |
|a Congress
|0 (DNLM)D016423
|
655 |
|
7 |
|a proceedings (reports)
|2 aat
|0 (CStmoGRI)aatgf300027316
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|0 (OCoLC)fst01423772
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congr�es.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001049
|
700 |
1 |
|
|a Emson, P. C.
|
700 |
1 |
|
|a Rossor, M.
|q (Martin)
|
700 |
1 |
|
|a Tohyama, M.
|q (Masaya)
|
776 |
|
|
|z 0-444-80733-0
|
830 |
|
0 |
|a Progress in brain research ;
|v 66.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780444807335
|z Texto completo
|